Author information:
(1)Institute for Molecular Bioscience, The University of Queensland, Brisbane, 
QLD, Australia.
(2)Australian Institute for Bioengineering and Nanotechnology, The University of 
Queensland, Brisbane, QLD, Australia.
(3)Department of Neuroscience, Neurology and Ophthalmology, Center for 
High-Throughput Biology and Institute for Cell Engineering, Johns Hopkins 
University School of Medicine, Baltimore, MD, USA.
(4)1] Schizophrenia Research Institute, Sydney, NSW, Australia [2] The 
University of Newcastle, Callaghan, NSW, Australia.
(5)Queensland Brain Institute, The University of Queensland, Brisbane, QLD, 
Australia.
(6)Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, 
The University of Queensland, St Lucia, QLD, Australia.
(7)Wilmer Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 
USA.
(8)RNA Biology Laboratory, RIKEN Advanced Research Institute, Wako, Saitama, 
Japan.
(9)Isis Pharmaceuticals, Carlsbad, CA, USA.
(10)1] Institute for Molecular Bioscience, The University of Queensland, 
Brisbane, QLD, Australia [2] Garvan Institute of Medical Research, Sydney, NSW, 
Australia [3] St Vincent's Clinical School and School of Biotechnology and 
Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.